Inhibition of angiogenesis using interleukin-12

Details Inhibition of angiogenesis using interleukin-12 Inhibition of angiogenesis using interleukin-12

A - Human Necessities

61

K

A61K 38/20 (2006.01)

Patent

CA 2212370

The present invention relates to the use of Interleukin-12 for the preparation of a medicament for the treatment of undesired or uncontrolled angiogenesis, which is important in the treatment of diabetic retinopathy and macular degeneration.

La présente invention concerne l'utilisation de l'interleukine-12 pour la préparation d'un médicament permettant de traiter l'angiogenèse indésirable ou non maîtrisée, ce qui est important pour le traitement de la rétinopathie diabétique et de la dégénérescence maculaire.

Affiliated with

Also associated with

Rating

Inhibition of angiogenesis using interleukin-12 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of angiogenesis using interleukin-12, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of angiogenesis using interleukin-12 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1352074